A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

  • Thomas J. Herzog
  • , Bradley J. Monk
  • , Peter G. Rose
  • , Patricia Braly
  • , Jeffrey F. Hines
  • , Maria C. Bell
  • , Robert M. Wenham
  • , Angeles Alvarez Secord
  • , Lynda D. Roman
  • , Mark H. Einstein
  • , Richard D. Drake
  • , Barrett H. Childs

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science